Federal Register / Vol. 77, No. 12 / Thursday, January 19, 2012 / Notices 2735 

effectiveness of a state-of-the-art 

software application for smart phones 

(i.e., mobile application), ‘‘Solar Cell.’’ 

This software application supports 

decision-making related to sun 

protection and exposure by Americans 

to reduce the risk of developing skin 

cancer attributable to chronic and severe 

UV exposure and developing other 

cancers attributable to vitamin D 

deficiency. The Solar Cell mobile smart 

phone application combines personal 

and behavior data with geo-spatial data 

(i.e., UV Index forecast, time, and 

location) and delivers actionable sun 

protection advice to reduce risk of skin 

cancer. Frequency of Response: Once. 

Affected Public: Individuals. Type of 

Respondents: Adults (18 and over) from 

the U.S. population who own Android 

smart phones. The annual reporting 

burden is estimated at 673 (see Table 

below). There are no Capital Costs, 

Operating Costs, and/or Maintenance 

Costs to report. 

A.12–1—ESTIMATES OF ANNUAL BURDEN HOURS

Type of respondents Instrument Number of 

respondents 

Frequency of 

response 

Average time per 

response 

(minutes/hour) 

Annual burden 

hours 

Adults .................................... Screener (Appendix G) ......... 1,875 1 15/60 (0.25) 469 

Pre-test (Appendix A) ........... 245 1 20/60 (0.33) 82 

Post-test (Appendix B) ......... 184 1 40/60 (0.66) 123 

Totals ............................. 2,304 673 

Request for Comments: Written 

comments and/or suggestions from the 

public and affected agencies should 

address one or more of the following 

points: (1) Evaluate whether the 

proposed collection of information is 

necessary for the proper performance of 

the function of the agency, including 

whether the information will have 

practical utility; (2) Evaluate the 

accuracy of the agency’s estimate of the 

burden of the proposed collection of 

information, including the validity of 

the methodology and assumptions used; 

(3) Enhance the quality, utility, and 

clarity of the information to be 

collected; and (4) Minimize the burden 

of the collection of information on those 

who are to respond, including the use 

of appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the data collection plans and 

instruments, contact Patricia Weber, 

DrPH, Program Director, NCI/NIH, SBIR 

Development Center, 6116 Executive 

Blvd., Suite 402, Rockville, MD 20852 

or call non-toll-free number (301) 594– 

8106 or email your request, including 

your address to: weberpa@mail.nih.gov. 

Comments Due Date: Comments 

regarding this information collection are 

best assured of having their full effect if 

received within 60 days of the date of 

this publication. 

Dated: January 11, 2012. 

Vivian Horovitch-Kelley, 

NCI Project Clearance Liaison, National 

Institutes of Health. 

[FR Doc. 2012–872 Filed 1–18–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Human Genome Research 

Institute; Notice of Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of meetings of the National 

Advisory Council for Human Genome 

Research. 

The meetings will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Council for Human Genome Research. 

Date: February 13–14, 2012. 

Open: February 13, 2012, 8:30 a.m. to 

3 p.m. 

Agenda: To discuss matters of program 

relevance. 

Place: National Institutes of Health, 5635 

Fishers Lane, Terrace Level Conference 

Room, Rockville, MD 20892. 

Closed: February 13, 2012, 3 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: National Institutes of Health, 5635 

Fishers Lane Terrace Level Conference Room, 

Rockville, MD 20892. 

Closed: February 14, 2012, 8:30 a.m. to 

5 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals National 

Institutes of Health, 5635 Fishers Lane, 

Terrace Level Conference Room, Rockville, 

MD 20892. 

Contact Person: Mark S. Guyer, Ph.D., 

Director for Extramural Research National 

Human Genome Research Institute, 5635 

Fishers Lane, Suite 4076, MSC 9305, 

Bethesda, MD 20892, (301) 496–7531 

guyerm@mail.nih.gov. 

Name of Committee: National Advisory 

Council for Human Genome Research. 

Date: May 21–22, 2012. 

Open: May 21, 2012, 8:30 a.m. to 3 p.m. 

Agenda: To discuss matters of program 

relevance. 

Place: National Institutes of Health, 5635 

Fishers Lane, Terrace Level Conference 

Room, Rockville, MD 20892. 

Closed: May 21, 2012, 3 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: National Institutes of Health, 5635 

Fishers Lane, Terrace Level Conference 

Room, Rockville, MD 20892. 

Closed:May 22, 2012, 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: National Institutes of Health, 5635 

Fishers Lane, Terrace Level Conference 

Room, Rockville, MD 20892. 

Contact Person: Mark S. Guyer, Ph.D., 

Director for Extramural Research, National 

Human Genome Research Institute, 5635 

Fishers Lane, Suite 4076, MSC 9305, 

Bethesda, MD 20892, (301) 496–7531, 

guyerm@mail.nih.gov. 

Name of Committee: National Advisory 

Council for Human Genome Research. 

Date: September 10–11, 2012. 

Open: September 10, 2012, 8:30 a.m. to 

3 p.m. 

mstockstill on DSK4VPTVN1PROD with NOTICES

2736 Federal Register / Vol. 77, No. 12 / Thursday, January 19, 2012 / Notices 

Agenda: To discuss matters of program 

relevance. 

Place: National Institutes of Health, 5635 

Fishers Lane, Terrace Level Conference 

Room, Rockville, MD 20892. 

Closed: September 10, 2012, 3 p.m. to 

5 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: National Institutes of Health, 5635 

Fishers Lane, Terrace Level Conference 

Room, Rockville, MD 20892. 

Closed: September 11, 2012, 8:30 a.m. to 

5 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: National Institutes of Health, 5635 

Fishers Lane, Terrace Level Conference 

Room, Rockville, MD 20892. 

Contact Person: Mark S. Guyer, Ph.D., 

Director for Extramural Research, National 

Human Genome Research Institute, 5635 

Fishers Lane, Suite 4076, MSC 9305, 

Bethesda, MD 20892, (301) 496–7531, 

guyerm@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

www.genome.gov/11509849, where an 

agenda and any additional information for 

the meeting will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.172, Human Genome 

Research, National Institutes of Health, HHS) 

Dated: January 11, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2012–890 Filed 1–18–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; NIAID Clinical Trial 

Planning and Implementation. 

Date: February 6–7, 2012. 

Time: 9 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications, 

Place: National Institutes of Health, 6700B 

Rockledge Drive, Bethesda, MD 20817, 

(Telephone Conference Call). 

Contact Person: James T. Snyder, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities/ 

NIAID, National Institutes of Health, 6700B 

Rockledge Drive, MSC 7616, Bethesda, MD 

20892–7616, (301) 451–2634, 

james.snyder@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: January 11, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2012–885 Filed 1–18–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Microbiology, 

Infectious Diseases and AIDS Initial Review 

Group; Microbiology and Infectious Diseases 

B Subcommittee. 

Date: February 8–9, 2012. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Courtyard by Marriott, 5520 

Wisconsin Avenue, Chevy Chase, MD 20815. 

Contact Person: Nancy Lewis Ernst, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institutes of Health/NIAID, 6700B 

Rockledge Drive, MSC 7616, Bethesda, MD 

20892–7616, (301) 451–7383, 

nancy.ernst@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: January 11, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2012–884 Filed 1–18–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

thediscussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; NIAID Clinical Trial 

Implementation Cooperative Agreement 

(U01). 

Date: February 7–8, 2012. 

Time: 2 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6700B 

Rockledge Drive, Bethesda, MD 20817, 

(Telephone Conference Call). 

Contact Person: James T. Snyder, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

DHHS/NIH/NIAID, 6700B Rockledge Drive, 

MSC 7616, Room # 3257, Bethesda, MD 

20892, (301) 435–1614, 

james.snyder@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

mstockstill on DSK4VPTVN1PROD with NOTICES